In glioma, some synthetic compounds have been found to induce the G1 phase arrest of tumor cells by inhibiting EZH2 expression and reducing the inhibitory effect of PRC2 on p21, p27, and p16 gene expression (Mohammad et al., 2017; Stazi et al., 2019). The gene discussed is CDKN2A; the disease is central nervous system cancer.